Holep Procedure

Holep Procedure

Holep Procedure

Benign prostatic hyperplasia (BPH) affects millions of men worldwide, and surgical intervention is often necessary when medications no longer provide adequate relief. The HoLEP procedure has emerged as one of the most effective and durable surgical options available for managing an enlarged prostate, offering lasting results with minimal complications across a wide range of prostate sizes.

Key Takeaways

  • HoLEP uses a holmium laser to remove obstructing prostate tissue through the urethra, requiring no external incisions.
  • It is effective for prostates of virtually any size, making it suitable for patients who may not qualify for other procedures.
  • HoLEP generally offers lower retreatment rates compared to TURP, with durable long-term outcomes.
  • Most patients are discharged within 24 hours, with urinary function typically improving within a few weeks.
  • Retrograde ejaculation is the most common side effect; serious complications such as urinary incontinence are rare.

What Is the HoLEP Procedure for Enlarged Prostate

Holmium laser enucleation of the prostate (HoLEP) is a minimally invasive surgical technique used to treat BPH by removing the obstructing inner tissue of the prostate gland. Unlike traditional open surgery, HoLEP is performed entirely through the urethra, meaning no skin incisions are required. A thin scope is inserted through the urethra, and a holmium laser is used to precisely separate and remove the obstructing prostate lobes.

BPH is a highly prevalent condition — the World Health Organization recognizes it as one of the most common urological disorders in aging men, with prevalence rising sharply after age 50 and affecting the majority of men by their eighth decade. When the enlarged prostate compresses the urethra, it causes urinary symptoms such as weak stream, frequent urination, incomplete bladder emptying, and nocturia. HoLEP addresses these symptoms at their anatomical source by removing the tissue responsible for the obstruction.

One of the distinguishing features of HoLEP is that it is size-independent, meaning it can be performed safely on small, medium, and very large prostates alike. This versatility makes it particularly valuable for patients with significantly enlarged glands who might otherwise require open prostatectomy. Because the removed tissue is sent for pathological analysis, HoLEP also provides the added benefit of prostate cancer screening from the excised specimen.

How the HoLEP Procedure Works: Holmium Laser Enucleation Explained

HoLEP is performed under spinal or general anesthesia and typically takes between 60 and 120 minutes, depending on prostate size and complexity. A rigid resectoscope is advanced through the urethra to reach the prostate. The surgeon then uses a holmium laser fiber to precisely dissect the adenoma — the inner, obstructing portion of the prostate — from the surrounding surgical capsule. This dissection follows natural tissue planes, which contributes to the precision and safety of the technique.

Once the lobes of the prostate tissue are freed from the capsule, they are pushed into the bladder. A separate instrument called a morcellator is then introduced into the bladder to fragment the tissue into smaller pieces that can be suctioned out through the scope. This two-stage process — enucleation followed by morcellation — allows large volumes of tissue to be removed without the need for open surgery. The holmium laser simultaneously seals blood vessels during the enucleation phase, which significantly reduces intraoperative bleeding.

Because HoLEP removes the obstructing tissue in its entirety rather than simply ablating or vaporizing it, the procedure achieves thorough decompression of the urethra. This completeness of tissue removal is one reason why retreatment rates following HoLEP are notably low. The technique requires specialized training and equipment, which is why it is offered at centers with dedicated expertise in advanced endourology.

HoLEP vs TURP: Candidacy, Risks, Benefits, and Outcomes

Transurethral resection of the prostate (TURP) has historically been the gold standard for surgical BPH treatment, but a HoLEP vs TURP comparison reveals meaningful differences. TURP uses an electrical loop to cut and remove prostate tissue in segments, while HoLEP removes the obstructing tissue more completely using laser energy. Multiple studies and systematic reviews have found that HoLEP produces equivalent or superior improvements in urinary flow rates and symptom scores, with a lower risk of long-term retreatment.

From a candidacy perspective, TURP is generally best suited for prostates under 80–100 grams, whereas HoLEP has no established upper size limit, making it the preferred option for men with very large prostates. Both procedures are appropriate for men with moderate-to-severe lower urinary tract symptoms who have not responded adequately to medical therapy. Men on anticoagulant medications may be better candidates for HoLEP due to the laser’s simultaneous hemostatic effect, which reduces bleeding risk during the procedure.

When evaluating the HoLEP procedure risks, benefits, and outcomes, the overall profile is favorable. The most common side effect is retrograde ejaculation — a condition in which semen enters the bladder during orgasm rather than exiting normally — occurring in the majority of patients. Temporary urinary incontinence or urgency may also occur in the early recovery period, though these effects typically resolve within weeks. Serious complications such as urethral stricture, persistent incontinence, or significant bleeding are uncommon. The table below summarizes a direct comparison of key clinical parameters.

Parameter HoLEP TURP
Prostate size suitability Any size Typically <80–100 g
Bleeding risk Lower (laser hemostasis) Moderate
Tissue removal for pathology Yes Yes
Retreatment rate (long-term) Lower Higher
Hospital stay Often <24 hours 1–2 days
Retrograde ejaculation risk High High

HoLEP Prostate Surgery Recovery Time and What to Expect

The HoLEP prostate surgery recovery time is generally shorter than that associated with open prostatectomy and comparable to or faster than TURP in many cases. A urinary catheter is placed at the end of the procedure to drain the bladder and is typically removed within 12 to 24 hours. Most patients are discharged from the hospital within one day of surgery, though some may require an additional night depending on individual recovery and urinary function at catheter removal.

In the first two to four weeks after surgery, patients commonly experience urinary urgency, increased frequency, and mild burning during urination. These symptoms are a normal part of the healing process as the bladder and urethra adjust to the anatomical changes. Strenuous physical activity, heavy lifting, and sexual intercourse are typically restricted for four to six weeks. Most men notice a significant improvement in urinary flow and symptom burden within the first month, with further gradual improvement over the following months.

Patients should maintain adequate hydration, follow up with their urologist as scheduled, and promptly report symptoms such as high fever, heavy bleeding, or complete inability to urinate. Men who are candidates for the HoLEP procedure should be aware of the retrograde ejaculation outcome and discuss fertility implications with their physician beforehand if this is a concern. Overall, the long-term prognosis is excellent — studies consistently show durable symptom relief with low rates of recurrence, positioning HoLEP as a highly effective treatment for BPH with a favorable balance of risk and benefit.

Frequently Asked Questions

Is HoLEP a permanent solution for an enlarged prostate?

For most patients, HoLEP provides long-lasting relief from BPH symptoms. Because the procedure removes the obstructing prostate tissue completely rather than reducing or ablating it, retreatment rates are low. Long-term studies show that the majority of patients maintain significant symptom improvement for ten or more years following the procedure. While the remaining prostate capsule can theoretically regrow over decades, this is uncommon and far less frequent than with procedures that leave more tissue behind.

Will HoLEP affect sexual function?

Retrograde ejaculation is the most expected sexual side effect of HoLEP, occurring in most patients. This means semen enters the bladder during orgasm instead of being expelled externally. While this can affect fertility, it does not reduce sexual pleasure or the ability to achieve an erection. Erectile dysfunction directly caused by HoLEP is rare, as the procedure avoids the nerves responsible for erection. Men concerned about fertility should discuss sperm banking or alternative treatments with their urologist prior to surgery.

How do I know if I am a good candidate for HoLEP?

Men with moderate-to-severe BPH symptoms that have not responded to medication, or who experience complications such as urinary retention, bladder stones, or recurrent infections, are generally suitable candidates. HoLEP is especially advantageous for men with very large prostates, those on blood thinners, or those who wish to avoid open surgery. A urologist will evaluate prostate size via ultrasound, review symptom severity, assess overall health status, and consider the patient’s preferences before recommending HoLEP as the appropriate surgical approach.

[EN] Cancer Types
Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Benign prostatic hyperplasia (BPH) affects millions of men worldwide, and surgical intervention is often necessary when medications no longer provide adequate relief. The HoLEP procedure has emerged as one of the most effective and durable surgical options available for managing an enlarged prostate, offering lasting results with minimal complications across a wide range of prostate sizes.

Key Takeaways

  • HoLEP uses a holmium laser to remove obstructing prostate tissue through the urethra, requiring no external incisions.
  • It is effective for prostates of virtually any size, making it suitable for patients who may not qualify for other procedures.
  • HoLEP generally offers lower retreatment rates compared to TURP, with durable long-term outcomes.
  • Most patients are discharged within 24 hours, with urinary function typically improving within a few weeks.
  • Retrograde ejaculation is the most common side effect; serious complications such as urinary incontinence are rare.

What Is the HoLEP Procedure for Enlarged Prostate

Holmium laser enucleation of the prostate (HoLEP) is a minimally invasive surgical technique used to treat BPH by removing the obstructing inner tissue of the prostate gland. Unlike traditional open surgery, HoLEP is performed entirely through the urethra, meaning no skin incisions are required. A thin scope is inserted through the urethra, and a holmium laser is used to precisely separate and remove the obstructing prostate lobes.

BPH is a highly prevalent condition — the World Health Organization recognizes it as one of the most common urological disorders in aging men, with prevalence rising sharply after age 50 and affecting the majority of men by their eighth decade. When the enlarged prostate compresses the urethra, it causes urinary symptoms such as weak stream, frequent urination, incomplete bladder emptying, and nocturia. HoLEP addresses these symptoms at their anatomical source by removing the tissue responsible for the obstruction.

One of the distinguishing features of HoLEP is that it is size-independent, meaning it can be performed safely on small, medium, and very large prostates alike. This versatility makes it particularly valuable for patients with significantly enlarged glands who might otherwise require open prostatectomy. Because the removed tissue is sent for pathological analysis, HoLEP also provides the added benefit of prostate cancer screening from the excised specimen.

How the HoLEP Procedure Works: Holmium Laser Enucleation Explained

HoLEP is performed under spinal or general anesthesia and typically takes between 60 and 120 minutes, depending on prostate size and complexity. A rigid resectoscope is advanced through the urethra to reach the prostate. The surgeon then uses a holmium laser fiber to precisely dissect the adenoma — the inner, obstructing portion of the prostate — from the surrounding surgical capsule. This dissection follows natural tissue planes, which contributes to the precision and safety of the technique.

Once the lobes of the prostate tissue are freed from the capsule, they are pushed into the bladder. A separate instrument called a morcellator is then introduced into the bladder to fragment the tissue into smaller pieces that can be suctioned out through the scope. This two-stage process — enucleation followed by morcellation — allows large volumes of tissue to be removed without the need for open surgery. The holmium laser simultaneously seals blood vessels during the enucleation phase, which significantly reduces intraoperative bleeding.

Because HoLEP removes the obstructing tissue in its entirety rather than simply ablating or vaporizing it, the procedure achieves thorough decompression of the urethra. This completeness of tissue removal is one reason why retreatment rates following HoLEP are notably low. The technique requires specialized training and equipment, which is why it is offered at centers with dedicated expertise in advanced endourology.

HoLEP vs TURP: Candidacy, Risks, Benefits, and Outcomes

Transurethral resection of the prostate (TURP) has historically been the gold standard for surgical BPH treatment, but a HoLEP vs TURP comparison reveals meaningful differences. TURP uses an electrical loop to cut and remove prostate tissue in segments, while HoLEP removes the obstructing tissue more completely using laser energy. Multiple studies and systematic reviews have found that HoLEP produces equivalent or superior improvements in urinary flow rates and symptom scores, with a lower risk of long-term retreatment.

From a candidacy perspective, TURP is generally best suited for prostates under 80–100 grams, whereas HoLEP has no established upper size limit, making it the preferred option for men with very large prostates. Both procedures are appropriate for men with moderate-to-severe lower urinary tract symptoms who have not responded adequately to medical therapy. Men on anticoagulant medications may be better candidates for HoLEP due to the laser’s simultaneous hemostatic effect, which reduces bleeding risk during the procedure.

When evaluating the HoLEP procedure risks, benefits, and outcomes, the overall profile is favorable. The most common side effect is retrograde ejaculation — a condition in which semen enters the bladder during orgasm rather than exiting normally — occurring in the majority of patients. Temporary urinary incontinence or urgency may also occur in the early recovery period, though these effects typically resolve within weeks. Serious complications such as urethral stricture, persistent incontinence, or significant bleeding are uncommon. The table below summarizes a direct comparison of key clinical parameters.

Parameter HoLEP TURP
Prostate size suitability Any size Typically <80–100 g
Bleeding risk Lower (laser hemostasis) Moderate
Tissue removal for pathology Yes Yes
Retreatment rate (long-term) Lower Higher
Hospital stay Often <24 hours 1–2 days
Retrograde ejaculation risk High High

HoLEP Prostate Surgery Recovery Time and What to Expect

The HoLEP prostate surgery recovery time is generally shorter than that associated with open prostatectomy and comparable to or faster than TURP in many cases. A urinary catheter is placed at the end of the procedure to drain the bladder and is typically removed within 12 to 24 hours. Most patients are discharged from the hospital within one day of surgery, though some may require an additional night depending on individual recovery and urinary function at catheter removal.

In the first two to four weeks after surgery, patients commonly experience urinary urgency, increased frequency, and mild burning during urination. These symptoms are a normal part of the healing process as the bladder and urethra adjust to the anatomical changes. Strenuous physical activity, heavy lifting, and sexual intercourse are typically restricted for four to six weeks. Most men notice a significant improvement in urinary flow and symptom burden within the first month, with further gradual improvement over the following months.

Patients should maintain adequate hydration, follow up with their urologist as scheduled, and promptly report symptoms such as high fever, heavy bleeding, or complete inability to urinate. Men who are candidates for the HoLEP procedure should be aware of the retrograde ejaculation outcome and discuss fertility implications with their physician beforehand if this is a concern. Overall, the long-term prognosis is excellent — studies consistently show durable symptom relief with low rates of recurrence, positioning HoLEP as a highly effective treatment for BPH with a favorable balance of risk and benefit.

Frequently Asked Questions

Is HoLEP a permanent solution for an enlarged prostate?

For most patients, HoLEP provides long-lasting relief from BPH symptoms. Because the procedure removes the obstructing prostate tissue completely rather than reducing or ablating it, retreatment rates are low. Long-term studies show that the majority of patients maintain significant symptom improvement for ten or more years following the procedure. While the remaining prostate capsule can theoretically regrow over decades, this is uncommon and far less frequent than with procedures that leave more tissue behind.

Will HoLEP affect sexual function?

Retrograde ejaculation is the most expected sexual side effect of HoLEP, occurring in most patients. This means semen enters the bladder during orgasm instead of being expelled externally. While this can affect fertility, it does not reduce sexual pleasure or the ability to achieve an erection. Erectile dysfunction directly caused by HoLEP is rare, as the procedure avoids the nerves responsible for erection. Men concerned about fertility should discuss sperm banking or alternative treatments with their urologist prior to surgery.

How do I know if I am a good candidate for HoLEP?

Men with moderate-to-severe BPH symptoms that have not responded to medication, or who experience complications such as urinary retention, bladder stones, or recurrent infections, are generally suitable candidates. HoLEP is especially advantageous for men with very large prostates, those on blood thinners, or those who wish to avoid open surgery. A urologist will evaluate prostate size via ultrasound, review symptom severity, assess overall health status, and consider the patient’s preferences before recommending HoLEP as the appropriate surgical approach.

[EN] Cancer Types
Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Massive Bio has onboarded over 160,000+ cancer patients to find their clinical trial

Most Recent Article